Formycon AG's (ETR:FYB) Share Price Not Quite Adding Up
Sep 26
German (DAX) Biotech Industry Analysis
UpdatedOct 03, 2023
DataAggregated Company Financials
Companies20
- 7D-1.9%
- 3M-7.2%
- 1Y-9.1%
- YTD-10.1%
Over the last 7 days, the Biotech industry has dropped 1.0%, driven by a pullback from MorphoSys of 11%. The industry has fallen 6.8% in the last year. As for the next few years, earnings are expected to grow by 65% per annum.
Industry Valuation and Performance
Has the German Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 03 Oct 2023 | €3.9b | €971.6m | -€197,588,171.00 | 9.7x | -19.6x | 4x |
| Thu, 31 Aug 2023 | €4.0b | €954.5m | -€53,175,027.00 | 19.1x | -74.7x | 4.2x |
| Sat, 29 Jul 2023 | €4.1b | €955.5m | -€219,213,323.00 | 29.2x | -18.7x | 4.3x |
| Mon, 26 Jun 2023 | €4.0b | €967.4m | -€212,883,319.00 | 27.9x | -18.9x | 4.2x |
| Wed, 24 May 2023 | €4.1b | €967.4m | -€209,726,026.00 | 35x | -19.6x | 4.3x |
| Fri, 21 Apr 2023 | €3.6b | €927.5m | -€212,539,789.00 | 13.6x | -16.9x | 3.9x |
| Sun, 19 Mar 2023 | €3.3b | €890.4m | -€224,291,844.00 | 9.9x | -14.9x | 3.8x |
| Tue, 14 Feb 2023 | €3.0b | €612.2m | -€74,748,337.00 | 11x | -40.6x | 5x |
| Thu, 12 Jan 2023 | €3.1b | €611.9m | -€53,407,435.00 | 11.6x | -57.6x | 5x |
| Sat, 10 Dec 2022 | €3.1b | €611.9m | -€53,407,435.00 | 11.3x | -57.4x | 5x |
| Mon, 07 Nov 2022 | €2.6b | €624.9m | -€39,165,157.00 | 8.1x | -65.2x | 4.1x |
| Wed, 05 Oct 2022 | €2.6b | €627.4m | -€129,805,157.00 | 5.1x | -19.7x | 4.1x |
| Fri, 02 Sep 2022 | €2.6b | €605.7m | -€150,021,513.00 | 5.7x | -17.5x | 4.3x |
| Sun, 31 Jul 2022 | €3.5b | €772.0m | -€724,268,362.00 | n/a | -4.8x | 4.5x |
| Tue, 28 Jun 2022 | €3.4b | €768.8m | -€724,082,241.00 | n/a | -4.7x | 4.4x |
| Thu, 26 May 2022 | €3.3b | €768.8m | -€724,082,241.00 | n/a | -4.6x | 4.3x |
| Sat, 23 Apr 2022 | €3.6b | €807.7m | -€693,827,813.00 | n/a | -5.2x | 4.5x |
| Mon, 21 Mar 2022 | €3.6b | €806.5m | -€675,731,845.00 | n/a | -5.3x | 4.4x |
| Wed, 16 Feb 2022 | €3.7b | €789.6m | -€311,283,353.00 | n/a | -11.8x | 4.7x |
| Fri, 14 Jan 2022 | €3.9b | €789.6m | -€311,283,353.00 | n/a | -12.6x | 5x |
| Sun, 12 Dec 2021 | €4.0b | €789.6m | -€311,690,565.00 | n/a | -12.8x | 5.1x |
| Tue, 09 Nov 2021 | €4.4b | €771.2m | -€257,628,521.00 | n/a | -17.2x | 5.7x |
| Thu, 07 Oct 2021 | €4.3b | €768.9m | -€232,876,055.00 | n/a | -18.5x | 5.6x |
| Sat, 04 Sep 2021 | €4.4b | €769.4m | -€175,243,228.00 | 1.4x | -24.9x | 5.7x |
| Mon, 02 Aug 2021 | €4.4b | €769.4m | -€175,243,228.00 | 1.3x | -24.9x | 5.7x |
| Thu, 06 May 2021 | €5.3b | €749.9m | -€236,050,839.00 | 1.1x | -22.6x | 7.1x |
| Sun, 07 Feb 2021 | €6.0b | €930.9m | -€76,599,954.23 | 33.1x | -79x | 6.5x |
| Sat, 31 Oct 2020 | €5.0b | €857.2m | -€136,640,199.02 | 55.3x | -36.9x | 5.9x |
Price to Earnings Ratio
-43.4x
Current Industry PE
- Investors are pessimistic on the German Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.1x is higher than the industry's current PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 4.3% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -1.19% | |
| Healthcare | -1.57% | |
| Biotech | -1.92% | |
| Biotech | -1.92% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| FYB Formycon | €57.30 | 4.4% +€38.5m | -20.6% | PS13.4x | |
| T9G Vidac Pharma Holding | €0.45 | 21.6% +€4.1m | n/a | n/a | |
| T5O bioXXmed | €1.48 | 5.7% +€411.0k | -20.4% | PS621.6x | |
| ECX1 Epigenomics | €0.69 | 6.2% +€170.7k | -50.4% | PS6.6x |